申请人:Loughhead Garrett David
公开号:US20060135555A1
公开(公告)日:2006-06-22
This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II:
wherein Ar is optionally substituted aryl or heteroaryl, R
1
-R
4
are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts thereof. The invention further relates to processes for preparing such compounds, to pharmaceutical compositions containing such compounds, and to methods for their use as therapeutic agents.
本发明涉及化合物,通常为CRF-1受体拮抗剂,其由公式I或公式II表示:其中Ar是可选的取代芳基或杂环芳基,R1-R4如规范所定义;或其单一异构体,外消旋或非外消旋异构体混合物,或其药学上可接受的盐。本发明还涉及制备这种化合物的方法,含有这种化合物的制药组合物,以及将其用作治疗剂的方法。